Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 621Physical Activity and HealthCardiovascular and exercise physiologyDiabetes Management and Research

The DOI matches its Crossref record, with a small difference in title or year; 121 of the 122 references it cites were found in a registry or an index.

Exercise and Type 2 Diabetes

Abstract

This pronouncement was written for the American College of Sports Medicine by: Ann Albright, Ph.D., R.D. (Chairperson); Marion Franz, M.S., R.D., C.D.E.; Guyton Hornsby, Ph.D., C.D.E.; Andrea Kriska, Ph.D., FACSM; David Marrero, Ph.D.; Irma Ullrich, M.D.; and Larry S. Verity, Ph.D., FACSM. SUMMARY Physical activity, including appropriate endurance and resistance training, is a major therapeutic modality for type 2 diabetes. Unfortunately, too often physical activity is an underutilized therapy. Favorable changes in glucose tolerance and insulin sensitivity usually deteriorate within 72 h of the last exercise session; consequently, regular physical activity is imperative to sustain glucose-lowering effects and improved insulin sensitivity. Individuals with type 2 diabetes should strive to achieve a minimum cumulative total of 1000 kcal·wk−1 from physical activities. Those with type 2 diabetes generally have a lower level of fitness (V̇O2max) than nondiabetic individuals, and therefore exercise intensity should be at a comfortable level (RPE 10–12) in the initial periods of training and should progress cautiously as tolerance for activity improves. Resistance training has the potential to improve muscle strength and endurance, enhance flexibility and body composition, decrease risk factors for cardiovascular disease, and result in improved glucose tolerance and insulin sensitivity. Modifications to exercise type and/or intensity may be necessary for those who have complications of diabetes. Individuals with type 2 diabetes may develop autonomic neuropathy, which affects the heart rate response to exercise, and as a result, ratings of perceived exertion rather than heart rate may need to be used for moderating intensity of physical activity. Although walking may be the most convenient low-impact mode, some persons, because of peripheral neuropathy and/or foot problems, may need to do non-weight-bearing activities. Outcome expectations may contribute significantly to motivation to begin and maintain an exercise program. Interventions designed to encourage adoption of an exercise regimen must be responsive to the individual’s current stage of readiness and focus efforts on moving the individual through the various “stages of change.” INTRODUCTION Diabetes is one of the leading causes of death and disability in the United States with type 2 diabetes accounting for 90–95% of all diabetic cases (77). Based on national data, there are about 10.3 million diagnosed cases of diabetes in the United States with an estimated 5.4 million additional undiagnosed cases in the general population (40). Unfortunately, the diagnosis of type 2 diabetes is often delayed for years after the onset of the disease. A large portion of the burden of the disease falls upon the minority populations of the U.S., demonstrated by the fact that the prevalence rates of diabetes are higher among Native Americans, African Americans, Hispanic Americans, and Asian and Pacific Island Americans when compared with non-Hispanic whites (99). The long-term complications associated with type 2 diabetes are both microvascular and macrovascular in nature and include the following: retinopathy, peripheral and autonomic neuropathy, nephropathy, peripheral vascular disease, atherosclerotic cardiovascular and cerebrovascular disease, hypertension, and susceptibility to infections and periodontal disease (for an extensive description of the complications associated with diabetes, the reader is referred to Diabetes in America, 1995; 80,81). The diagnosis and classification of diabetes have been revised by the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (59). The new classification system emphasizes etiology and pathogenesis rather than modalities of treatment. Diabetes is divided into four major categories depending on etiology: type 1, type 2, gestational, and type diabetes, the is by which to insulin 2 diabetes is by of insulin resistance and insulin diabetes is as of glucose with onset The diabetes to and (59). for diabetes have been revised and are than the The new the prevalence of microvascular complications for diabetes. of must be for the diagnosis of a glucose of diabetes as and a glucose of and glucose an glucose tolerance of there is should be on a (59). and factors have been in the etiology of type 2 diabetes. is a for type of diabetes the are (59). the risk for the disease are minority and lower with type 2 diabetes factors that are in the of type 2 diabetes are physical and and 2 diabetes is a disease in which often insulin with The of type 2 diabetes to in both insulin and resistance is by of glucose as in the and the level muscle glucose may be from to and are is an in and may a is a with by as a that of as may be an in the by which are into the in insulin have been to be in insulin A in may and be in nondiabetic of with type 2 diabetes in insulin may be through factors as and may contribute to insulin resistance of m

Overview

Integrity signals

Registry

Crossref · 10.1097/00005768-200007000-00024

Cites

121 of 121 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 122 references

Research works printed but not linked: 63

  1. Ajzen, 1980, Englewood Cliffs, NJ, Prentice
  2. 1993, Med Sci Sports Exerc, 25, i???x,
  3. 1999, Diabetes Care, 22, S24???S31,
  4. 1993, Diabetes Care, 16, 72???78,
  5. 1998, Diabetes Care, 21, 310???314,
  6. 1999, Diabetes Care, 22, S49???S53,
  7. 1989, Diabetes Care, 12, 573???79,
  8. 1995, Circulation, 91, 580???615,
  9. Ballor, 1996, Metabolism, 45, 179???183,
  10. Barnard, 1982, Diabetes Care, 5, 370???374,
  11. Barnard, 1992, J Cardiopulm Rehabil, 12, 194???201,
  12. Berntorp, 1986, Diabetes Res, 3, 231???236,
  13. Bj??rntorp, 1988, Diabetes Metab Rev, 4, 615???622,
  14. Bj??rntorp, 1991, Diabetes Care, 14, 1132???1143,
  15. Bj??rntorp, 1990, Arteriosclerosis, 10, 493???496,
  16. Bj??rntorp, 1992, Int J Obes Suppl, 16, 519???527,
  17. Bourn, 1995, Diabetes Care, 17, 1311???1319,
  18. Cederholm, 1985, Acta Med Scand, 217, 373???378,
  19. 1993, Sports Med Bull, 28, 7,
  20. 1999, Diabetes Care, 22, 623???634,
  21. Dowse, 1991, Diabetes Care, 14, 271???282,
  22. Eriksson, 1996, Diabetologia, 39, 573???579,
  23. Eriksson, 1991, Diabetologia, 34, 891???898,
  24. 1997, Diabetes Care, 20, 1183???1197,
  25. Greene, 1993, Diabetes Spectrum, 6, 234,
  26. Heath, 1983, J Appl Physiol, 57, 1857???1864,
  27. Hickey, 1995, Am J Physiol, 268, E453???E457,
  28. Holloszy, 1987, Acta Med Scand, 711, 55???65,
  29. Hubinger, 1987, Diabetes Res, 4, 57???61,
  30. Kahn, 1998, Cell, 92, 593???596,
  31. Kelley, 1984, J Psychosom Res, 28, 279???287,
  32. King, 1993, Diabetes Care, 16, 157???177,
  33. Koivisto, 1984, Acta Endocrinol, 262, 107???111,
  34. Leon, 1984, J Cardiopulm Rehabil, 4, 278???286,
  35. Lindg??rde, 1981, Diabetologia, 20, 134???138,
  36. McAuley, 1993, J Gerontol Psychol Sci, 48, 218???224,
  37. Miller, 1984, Med Sci Sports Exerc, 16, 539???543,
  38. Minuk, 1981, Am J Physiol, 240, E458???E464,
  39. 1987, Diabetes Care, 10, 639???644,
  40. Nyholm, 1996, Diabetoligia, 39, 813???822,
  41. Pan, 1997, Diabetes Care, 20, 537???544,
  42. Perry, 1995, Br Med J, 310, 560???564,
  43. Poehlman, 1992, Metabolism, 41, 1351???1360,
  44. Prochaska, 1994, Adv Med Sociol, 4, 141???161,
  45. Randle, 1963, Lancet, 21, 785???789,
  46. Reaven, 1994, Clinical Diabetes, 12, 32???36,
  47. Ronnemaa, 1988, Diabetes Res, 7, 79???84,
  48. R??nnemaa, 1986, Acta Med Scand, 220, 219???224,
  49. Ruderman, 1979, Diabetes, 28, 89???92,
  50. Ryan, 1996, J Gerontol A Biol Sci Med Sci, 51, M199???M205,
  51. Saltin, 1979, Diabetes, 28, 30???32,
  52. Santiago, 1986, Clin Chem, 32, B48???B53,
  53. Schneider, 1990, Diabetes Care, 17, 924???937,
  54. Shulman, 1990, N Engl J Med, 322, 223???228,
  55. Skinner, 1994, Am J Public Health, 84, 43???49,
  56. Stalonas, 1978, J Consult Clin Psychol, 46, 463???469,, 10.1037/0022-006x.46.3.463 · doi:10.1037/0022-006x.46.3.463
  57. Stern, 1991, Diabetes Care, 14, 399???410,
  58. Taylor, 1984, Diabetologia, 27, 578???582,
  59. Treuth, 1995, J Appl Physiol, 78, 1425???1431,
  60. Trovati, 1984, Diabetes Care, 7, 416???420,
  61. Van Gaal, 1988, Diabetes Care, 11, 103???106,
  62. Vranic, 1979, Diabetes, 28, 147???163,
  63. Yki-Jarvinen, 1992, Endocr Rev, 13, 415???431,

Cited by

See all 621

Metadata

Authors
Albright, A. J., FRANZ, M. M., Hornsby, W. G., Kriska, A. M., Marrero, D. G., Ullrich, I. H., & Verity, L.
Venue
Medicine & Science in Sports & Exercise
Published
2000-07
Volume
32
Issue
7
Pages
1345-1360
ISSN
0195-9131 (ISSN-L)
OpenAlex
W2416937488
Cited by
604
References
122
Citations by year
2026: 3 · 2025: 8 · 2024: 8 · 2023: 5 · 2022: 16 · 2021: 14 · 2020: 9 · 2019: 15 · 2018: 29 · 2017: 22 · 2016: 25 · 2015: 27 · 2014: 31 · 2013: 24 · 2012: 36
FWCI
6.62
Type
journal article
Language
en
Open access
closed
Locations
  • Medicine & Science in Sports & Exercise (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Physical Activity and Health
  • Health Sciences › Medicine › Physiology (medical) › Cardiovascular and exercise physiology
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
type 2 diabetes, exercise therapy, physical activity, resistance training, endurance training, insulin sensitivity, glucose tolerance, autonomic neuropathy, peripheral neuropathy, exercise intensity, rating of perceived exertion, stages of change, exercise motivation, walking, cardiovascular risk factors, body composition, diabetes complications, exercise prescription, exercise adherence
MeSH terms
Cardiovascular Diseases, Diabetes Mellitus, Type 2, Humans, Hypoglycemia, Insulin Resistance, Oxygen Consumption, Physical Fitness, Risk Factors, Weight Loss, Exercise, Walking, Weight-Bearing, Peripheral Vascular Diseases, Guidelines as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Exercise and Type 2 Diabetes. https://app.cochat.ai/papers/10.1097/00005768-200007000-00024
The paper
Albright, A. J., FRANZ, M. M., Hornsby, W. G., Kriska, A. M., Marrero, D. G., Ullrich, I. H., & Verity, L. (2000). Exercise and Type 2 Diabetes. Medicine & Science in Sports & Exercise. https://doi.org/10.1097/00005768-200007000-00024

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.